These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20424243)

  • 1. Depression severity and effect of antidepressant medications.
    Elkin I
    JAMA; 2010 Apr; 303(16):1596; author reply 1599. PubMed ID: 20424243
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression severity and effect of antidepressant medications.
    Hicks P; Hicks XP
    JAMA; 2010 Apr; 303(16):1598; author reply 1599. PubMed ID: 20424247
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of antidepressant therapy. A follow-up study.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1971; 13(3):162-3. PubMed ID: 5113821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined therapy in endogenous depression].
    Bilikiewicz A
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1153-7. PubMed ID: 5993463
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ; Conesa A;
    Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z; Gonda X
    J Affect Disord; 2008 Jun; 108(3):195-8. PubMed ID: 18280581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.
    Hekimian LJ; Gershon S; Floyd A
    Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between baseline severity of depression and antidepressant treatment outcome.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Riedel M; Möller HJ
    Pharmacopsychiatry; 2011 Jan; 44(1):27-32. PubMed ID: 20981642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression severity and effect of antidepressant medications.
    Finkelstein MM
    JAMA; 2010 Apr; 303(16):1596-7; author reply 1599. PubMed ID: 20424242
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression severity and effect of antidepressant medications.
    Glassman AH
    JAMA; 2010 Apr; 303(16):1598; author reply 1599. PubMed ID: 20424246
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating partial responders to antidepressant treatment.
    Trivedi MH
    J Clin Psychiatry; 2009 Sep; 70(9):e31. PubMed ID: 19818237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggestion in the treatment of depression.
    Kirsch I; Low CB
    Am J Clin Hypn; 2013 Jan; 55(3):221-9. PubMed ID: 23488249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-analysis of the earliest controlled trials of imipramine.
    Undurraga J; Tondo L; Schalkwijk S; Vieta E; Baldessarini RJ
    J Affect Disord; 2013 May; 147(1-3):451-4. PubMed ID: 23246207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both paroxetine and imipramine appear to be ineffective in adolescents with major depression, furthermore doubts have risen about their safety.
    Birkenhager TK
    Evid Based Med; 2016 Jun; 21(3):92. PubMed ID: 26887424
    [No Abstract]   [Full Text] [Related]  

  • 15. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding placebo response in pediatric depression trials.
    Emslie GJ
    Am J Psychiatry; 2009 Jan; 166(1):1-3. PubMed ID: 19122009
    [No Abstract]   [Full Text] [Related]  

  • 17. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Mallinckrodt CH; Prucka WR
    Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the problem of a high placebo response unique to antidepressant trials?
    Khan A; Bhat A
    J Clin Psychiatry; 2008 Dec; 69(12):1979-80. PubMed ID: 19203480
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.